Differences Put Aside As ICH Finalizes Guide On Post Approval Changes
Final Q12 Document Adopted At Singapore Meeting
An international guideline on managing post approval changes to drugs, which was initially criticized because of its incompatibility with legal frameworks in certain ICH regions such as the EU, has been finalized.
You may also be interested in...
Accelerating post-approval change oversight by focusing on ‘established conditions’ means trusting pharmaceutical quality management systems. But how?
Two EU bodies want to move forward with European Commission proposals on contamination of the environment by pharmaceutical substances.
Brazil’s pharmaceutical industry has welcomed the election of medicines regulator ANVISA to the management committee of the International Council for Harmonization.